VXUS is an ETF issued by Vanguard that seeks to track the FTSE Global All Cap ex US Index, which measures the investment return of stocks issued by companies located outside the United States. VXUS holds 7760 stocks, with net assets totaling $416.8 billion and an expense ratio of only 0.08% this ETF is extremely attractive for exposure to mostly large cap global equities. With the recent identification of a new variant of Covid the ETF's price has started to decline quite quickly. Viewing this ETF as a long term investment declines in price due to market panics are seen as excellent opportunities to purchase shares at reduced prices. As price declines I will continue to gradually increase the size of my position in this fund. Recent events have shown us that the perceived disruptions and negative effects of the Covid pandemic have not been nearly as detrimental to business as previously thought and so any undue panic simply represent an opportunity for patient, dispassionate investors to pick up bargains.
*Not a recommendation to buy or sell*
*Not a recommendation to buy or sell*